Inhibrx Biosciences, Inc. · NASDAQ:INBX
Inhibrx Biosciences, Inc. shareholders
As of Sep 30, 2026, 166 institutions reported holding Inhibrx Biosciences, Inc., 98.3% of its shares. Largest: Morgan Stanley, Perceptive Advisors LLC and Sanofi. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Inhibrx Biosciences, Inc. | Change | Filed |
|---|---|---|---|---|
| Morgan Stanley | 1.32M | 9.0% | +12,610 | Nov 13, 2026 |
| Perceptive Advisors LLC | 1.29M | 8.8% | −5,300 | Nov 16, 2026 |
| Sanofi | 1.16M | 7.9% | no change | Nov 5, 2026 |
| Viking Global Investors LP | 1.11M | 7.5% | −15,921 | Nov 16, 2026 |
| HighTower Advisors, LLC | 884K | 6.0% | +13,890 | Nov 9, 2026 |
| Schonfeld Strategic Advisors LLC | 827K | 5.6% | +130K | Nov 16, 2026 |
| BlackRock | 822K | 5.6% | −4,046 | Nov 13, 2026 |
| Vanguard | 733K | 5.0% | +33,826 | Nov 13, 2026 |
| TIG Advisors, LLC | 678K | 4.6% | new | Nov 16, 2026 |
| State Street | 566K | 3.8% | −74,709 | Nov 12, 2026 |